VistaGen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · IEX Real-Time Price · USD
4.750
-0.140 (-2.86%)
At close: Apr 15, 2024, 4:00 PM
4.720
-0.030 (-0.63%)
After-hours: Apr 15, 2024, 7:22 PM EDT
VistaGen Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for VTGN stock have an average target of 19, with a low estimate of 12 and a high estimate of 30. The average target predicts an increase of 300.00% from the current stock price of 4.75.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 7, 2023.
Analyst Ratings
The average analyst rating for VTGN stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $0.2 → $15 | Hold → Strong Buy | Upgrades | $0.2 → $15 | +215.79% | Dec 7, 2023 |
| Stifel | Stifel | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +152.63% | Nov 14, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +531.58% | Sep 5, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +531.58% | Aug 7, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 26, 2022 |
Financial Forecast
Revenue This Year
1.08M
from -227.30K
Revenue Next Year
206.81K
from 1.08M
Decreased by -80.89%
EPS This Year
-1.63
from -8.51
EPS Next Year
-2.00
from -1.63
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 1.3M | 431,550 | n/a | n/a | 73.3M | 273.4M |
| Avg | 1.1M | 206,805 | n/a | n/a | 71.2M | 265.6M |
| Low | 849,660 | n/a | n/a | n/a | 68.5M | 255.2M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | -60.1% | - | - | - | 283.7% |
| Avg | - | -80.9% | - | - | - | 272.8% |
| Low | - | - | - | - | - | 258.1% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -1.53 | -1.91 | -1.52 | -1.58 | -0.93 | 1.35 |
| Avg | -1.63 | -2.00 | -1.58 | -1.53 | -0.91 | 1.32 |
| Low | -1.71 | -2.03 | -1.62 | -1.47 | -0.87 | 1.26 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | - |
| Avg | - | - | - | - | - | - |
| Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.